tirzepatide injection vs sublingual — Medical Weight Loss Tirzepatide Oral Sublingual Tablets in

Originally developed for type 2 diabetes, Semaglutide (known by brand names Ozempic and Wegovy) has shown remarkable efficacy for weight management -- with clinical trials demonstrating average weight loss of 15-20% of body weight

When used as part of CagriSema, the dosing schedule looked like this in trials: Weeks 04: 0.25 mg cagrilintide + 0.25 mg semaglutide Weeks 48: 0.5 mg + 0.5 mg Weeks 812: 1 mg + 1 mg Weeks 1216: 1.7 mg + 1.7 mg Week 16 onward: 2.4 mg + 2.4 mg (full maintenance dose) Until the medication is approved and prescribing information is finalized, any dosing decisions would only happen through participation in a clinical trial or, eventually, under the guidance of a healthcare provider

There are ongoing clinical trials looking at creatines potential utility in curbing unwanted side effects from brain surgery

M.HarnettW